Novocure’s device for metastatic NSCLC treatment gains CE Mark
Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer…
Respiratory
-
-
AccuStem to launch MSC blood test for lung cancer screening in US
AccuStem Sciences is set to launch the microRNA Signature Classifier (MSC) blood test for the US lung cancer screening programmes.…
-
UNSW Sydney develops AI breath test for silicosis diagnosis
A team from Australia’s University of New South Wales (UNSW) Sydney has developed an AI-powered breath test for the diagnosis…
-
Leadoptik and Stanford Medicine to explore imaging in lung biopsy procedures
Leadoptik has entered a research partnership with Stanford Medicine, focusing on AI-enhanced real-time optical imaging usage in lung cancer biopsy.…
-
AccuStem Sciences acquires licence for lung cancer screening test
Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) test, which aims to…
-
Australia’s TGA approves Body Vision’s AI imaging system
Australia’s Therapeutic Goods Administration (TGA) has approved Body Vision Medical’s AI-powered advanced imaging system, LungVision, intended to improve the early…
-
FDA grants 510(k) clearance for Visby’s respiratory infections detection test
The US Food and Drug Administration (FDA) has granted 510(k) clearance and a Clinical Laboratory Improvement Amendments (CLIA) waiver for…
-
FDA clears Hologic’s Aptima SARS-CoV-2 assay
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Hologic's Aptima SARS-CoV-2 assay, marking an advancement since…
-
Australian TGA authorises marketing of Beyond Air’s LungFit PH system
The Australian Therapeutic Goods Administration (TGA) has granted authorisation to market Beyond Air’s LungFit PH as a Class IIb medical…
-
OXcan raises $11m to develop liquid biopsy tests for early cancer detection
Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests…
